Wells Fargo lowered the firm’s price target on Accolade to $6 from $7 and keeps an Equal Weight rating on the shares. Accolate is making progress on margins and the reiterated FY25 guidance seems achievable, but upside is likely limited due to top-line progression uncertainty driven by a mix shift to Usage fees, deal timing, and pressures on CAC, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Accolade price target lowered to $7.50 from $9 at Truist
- Accolade price target lowered to $7 from $13 at Canaccord
- Accolade price target lowered to $5.75 from $7 at BofA
- Accolade price target lowered to $5 from $5.50 at Barclays
- PepsiCo reports mixed Q3, Roblox slips after short report: Morning Buzz